Nobel Biocare flags difficult 2013 after Q4 net profit drops
ZURICH Feb 19 (Reuters) - Swiss dental implant maker Nobel Biocare said it expects difficult conditions this year, after fourth-quarter net profit dropped 16 percent to 11.2 million euros ($14.95 million) amid a sharp fall in sales in Japan.
Nobel, hard hit by a faltering global economy, said it would lift its dividend to 0.20 Swiss francs ($0.22) a share, from 0.15 in 2011.
"Within the next 3 to 5 years, assuming markets improve beyond 2013 to modest mid-single digit growth, Nobel Biocare targets growing at least in line with the market and to improve EBIT margin also continually between 50 to 100 bps per annum at constant exchange rates," the company said in a statement on Tuesday. ($1 = 0.7490 euros) ($1 = 0.9238 Swiss francs) (Reporting By Katharina Bart)
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- Scots spurn independence in historic vote, devolution battle begins |
- Eight bodies found after attack on Guinea Ebola education team
- Alibaba surges 38 percent on massive demand in market debut |
- Special Report: Scotland stays in UK, but Britain faces change